Olaris Honored to Recieve BostInno's 50 on Fire 2020 Award

Olaris was selected for BostInno's 50 on Fire award for our Biomarkers of Response platform to determine whether a patient will respond to certain drugs or treatments for certain types of diseases. Our technology was recognized by STAT for developing biomarker-based tests over the past year for metastatic breast cancer, metastatic gastrointestinal stromal tumors, Parkinson’s Disease and for immunosuppressive drugs given before a kidney transplant.

October 26, 2020

Olaris Honored to Recieve BostInno's 50 on Fire 2020 Award